Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

Cited by (622)

Items 201–300 of 622

1. Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations
   Gerald Francis Watts, Amanda Juniper, Frank van Bockxmeer, Zanfina Ademi, Danny Liew, Peter C. O'Leary · 2012 · International Journal of Evidence-Based Healthcare
2. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): A study protocol
   Jéssica Bassani Borges, Victor Fernandes de Oliveira, Gláucio Monteiro Ferreira, Bruna Los, Thais Kristini Almendros Barbosa, Elisangela da Silva Rodrigues Marçal, Carolina Dagli-Hernandez, Renata Caroline Costa de Freitas, Raul Hernandes Bortolin, Augusto Akira Mori et al. · 2020 · Research in Social and Administrative Pharmacy
3. A new phenotypic classification system for dyslipidemias based on the standard lipid panel
   Maureen L. Sampson, Rami A. Ballout, Daniel E. Soffer, Anna T Wolska, Sierra R. Wilson, Jeffrey W. Meeusen, Leslie J. Donato, Erica M. Fatica, James D. Otvos, Eliot A. Brinton et al. · 2021 · Lipids in Health and Disease
4. LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
   Christos V. Rizos, Ioannis Skoumas, Lοukianos S. Rallidis, Emmanouil I. Skalidis, Κωνσταντίνος Τζιόμαλος, Anastasia Garoufi, Panagiotis G. Anagnostis, George Sfikas, Vasilios Kotsis, Michael N. Doumas et al. · 2021 · International Journal of Cardiology
5. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia
   Gisle Langslet, Leiv Ose · 2013 · Expert Review of Cardiovascular Therapy
6. Familial hypercholesterolemia: Detect, treat, and ask about family
   Nishant P. Shah, Haitham M. Ahmed, W.H. Wilson Tang · 2020 · Cleveland Clinic Journal of Medicine
7. Detecting Familial hypercholesterolemia in children and adolescents: potential and challenges
   Giuseppe Banderali, Maria Elena Capra, Giacomo Biasucci, Rita Stracquadaino, Claudia Viggiano, Cristina Pederiva · 2022 · The Italian Journal of Pediatrics/Italian journal of pediatrics
8. Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
   Laney K. Jones, Nicole Walters, Andrew Brangan, Catherine D. Ahmed, Michael H. Gatusky, Gemme Campbell‐Salome, Ilene Ladd, Amanda Sheldon, Samuel S. Gidding, Mary P. McGowan et al. · 2021 · Journal of Personalized Medicine
9. Preventing Early Cardiovascular Death in Patients With Familial Hypercholesterolemia
   Thomas B. Repas, J. Ross Tanner · 2014 · Journal of Osteopathic Medicine
10. Emerging low-density lipoprotein therapies: Microsomal triglyceride transfer protein inhibitors
    Anne Carol Goldberg · 2013 · Journal of clinical lipidology
11. Long-term follow-up in patients with homozygous familial hypercholesterolemia; 13-year experience of a university hospital lipid clinic
    Meral Kayıkçıoğlu · 2014 · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
12. Case Report: Liver Transplantation in Homozygous Familial Hypercholesterolemia (HoFH)—Long-Term Follow-Up of a Patient and Literature Review
    Matej Mlinarič, Nevenka Bratanič, Vlasta Dragoš, Ajda Skarlovnik, Matija Cevc, Tadej Battelino, Urh Grošelj · 2020 · Frontiers in Pediatrics
13. A Clinical Guide to Combination Lipid-Lowering Therapy
    Cori E. Russell, Samip Sheth, Douglas Jacoby · 2018 · Current Atherosclerosis Reports
14. Genetics of Dyslipidemia and Ischemic Heart Disease
    Kavita Sharma, Ragavendra R. Baliga · 2017 · Current Cardiology Reports
15. New approach for detection of LDL-hypercholesterolemia in the pediatric population: The Fr1dolin-Trial in Lower Saxony, Germany
    Olga Kordonouri, Karin Lange, Isa Boettcher, Juergen Christoph, Erika Marquardt, C Tombois, Laura Galuschka, Doris Stiller, Iris Mueller, Frank Roloff et al. · 2018 · Atherosclerosis
16. Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents
    Hayato Tada, Masayuki Takamura, Masa‐aki Kawashiri · 2021 · Vascular Health and Risk Management
17. Evaluation and management of blood lipids through a woman's life cycle
    Jyoti Sharma, Jan McAlister, Niti R. Aggarwal, Janet Wei, Puja K. Mehta, Odayme Quesada, Deirdre J. Mattina, Nandita S. Scott, Erin D. Michos, Zainab Mahmoud et al. · 2022 · American Journal of Preventive Cardiology
18. Familial hypercholesterolemia in children and adolescents: A clinical perspective
    Sarah D. de Ferranti · 2015 · Journal of clinical lipidology
19. ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic–therapeutic pathway in Italy
    Michele Massimo Gulizia, Furio Colivicchi, Gualtiero Ricciardi, Simona Giampaoli, Aldo Pietro Maggioni, Maurizio Rocco Averna, Maria Stella Graziani, Ferruccio Ceriotti, Alessandro Mugelli, Francesco Rossi et al. · 2017 · European Heart Journal Supplements
20. A novel approach to screening for familial hypercholesterolemia in a large public venue
    Megan Campbell, Jessa Humanki, Heather A. Zierhut · 2016 · Journal of Community Genetics
21. Genes Potentially Associated with Familial Hypercholesterolemia
    С. В. Михайлова, Д. Е. Иванощук, О. В. Тимощенко, Е. В. Шахтшнейдер · 2019 · Biomolecules
22. Cost-effectiveness of population-wide genomic screening for familial hypercholesterolemia in the United States
    Scott Spencer, Laney K. Jones, Gregory F. Guzauskas, Jing Hao, Marc S. Williams, Josh F. Peterson, David Leroy Veenstra · 2022 · Journal of clinical lipidology
23. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9
    Michael M. Page, Claudia Stefanutti, Allan D. Sniderman, Gerald Francis Watts · 2015 · Clinical Science
24. The efficacy and safety of ezetimibe coadministered with statin therapy in various patient groups
    Alberico Luigi Catapano, Peter Paul Toth, Joanne E. Tomassini, Andrew M. Tershakovec · 2013 · Clinical Lipidology
25. Universal cholesterol screening of children in community-based ambulatory pediatric clinics
    Don P. Wilson, Sharon Davis, Sarah Matches, Deep Shah, Van Leung‐Pineda, Margaret Mou, Luke Hamilton, Catherine J. McNeal, W. Paul Bowman · 2015 · Journal of clinical lipidology
26. Identification and Treatment of Patients with Homozygous Familial Hypercholesterolaemia: Information and Recommendations from a Middle East Advisory Panel
    Abdullah A. Al-Ashwal, Fahad Alnouri, Hani Mohamed Sabbour, Abdulraof Almahfouz, Nasreen Al-Sayed, Maryam Razzaghy‐Azar, Faisal Ahmad Al-Allaf, Khalid Al-Waili, Yajnavalka Banerjee, Jacques J. Genest et al. · 2015 · Current Vascular Pharmacology
27. Stakeholder Views on Active Cascade Screening for Familial Hypercholesterolemia
    Carla Geertruida van El, Valentina Baccolini, Péter Pikó, Martina Cornelia Cornel · 2018 · Healthcare
28. Racial/Ethnic Disparities in Screening for and Awareness of High Cholesterol Among Pregnant Women Receiving Prenatal Care
    Reed Mszar, Dipika J. Gopal, Rupa Chowdary, Cara Lea Smith, Cara D. Dolin, Melinda L. Irwin, Daniel E. Soffer, Richard Nemiroff, Jennifer Lewey · 2020 · Journal of the American Heart Association
29. Daily life, experience and needs of persons suffering from homozygous familial hypercholesterolaemia: Insights from a patient survey
    Éric Bruckert, Samir Saheb, Juliette Roth Bonté, Carole Coudray‐Omnès · 2014 · Atherosclerosis Supplements
30. The Impact of Lipoprotein‐Associated Oxidative Stress on Cell‐Specific Microvesicle Release in Patients with Familial Hypercholesterolemia
    Morten Hjuler Nielsen, H. Irvine, S. Vedel, Bent Raungaard, Henning Beck‐Nielsen, Aase Handberg · 2016 · Oxidative Medicine and Cellular Longevity
31. Familial Hypercholesterolemia: Advances in Recognition and Therapy
    Jacqueline L. Cartier, Anne Carol Goldberg · 2016 · Progress in Cardiovascular Diseases
32. Parent–child genetic testing for familial hypercholesterolaemia in an Australian context
    Jing Pang, Andrew C. Martin, Timothy R. Bates, Amanda J. Hooper, Damon A. Bell, John R. Burnett, Richard Norman, Gerald Francis Watts · 2018 · Journal of Paediatrics and Child Health
33. From bench side to clinic: Potential and challenges of RNA vaccines and therapeutics in infectious diseases
    Pandey, Manish, Ojha, Divya, Bansal, Sakshi, Rode, Ambadas B., Chawla, Geetanjali · 2021 · Molecular Aspects of Medicine
34. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study
    Stephen Franklin Weng, Joe Kai, Jennifer Tranter, Jo Leonardi‐Bee, Nadeem Qureshi · 2018 · Atherosclerosis
35. Familial hypercholesterolemia in Southeast and East Asia
    Candace L. Jackson, Magdi Zordok, Iftikhar J. Kullo · 2021 · American Journal of Preventive Cardiology
36. Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar – 2021
    Maria Cristina de Oliveira Izar, Viviane Zorzanelli Rocha, Adriana Bertolami, Raul Dias Santos, Ana Maria Lottenberg, Marcelo Heitor Vieira Assad, José Francisco Kerr Saraiva, Ana Paula Marte Chacra, Tânia Leme da Rocha Martinez, Luciana Bahia et al. · 2021 · Arquivos Brasileiros de Cardiologia
37. Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation
    Hana Bangash, Ahmed Makkawy, Justin H. Gundelach, Alexandra A. Miller, Kimberly A Jacobson, Iftikhar J. Kullo · 2021 · JMIR Human Factors
38. Cascade Screening in Familial Hypercholesterolemia: Advancing Forward
    Raul Dias Santos, Thiago Silva Frauches, Ana Paula Marte Chacra · 2015 · Journal of Atherosclerosis and Thrombosis
39. Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
    Ingunn Molven, Kjetil Retterstøl, Lene Frost Andersen, Marit Bragelien Veierød, Ingunn Narverud, Leiv Ose, Arne Svilaas, Margareta Wandel, Kirsten Bjørklund Holven · 2013 · Journal of Nutritional Science
40. Variable expressivity and co‐occurrence of LDLR and LDLRAP1 mutations in familial hypercholesterolemia: failure of the dominant and recessive dichotomy
    Akl C. Fahed, Ruby Ibrahim Khalaf, Rony H. Salloum, Rabih R. Andary, Raya Safa, Inaam El‐Rassy, Elie M. Moubarak, Sami T. Azar, Fadi Fouad Bitar, Georges M. Nemer · 2016 · Molecular Genetics & Genomic Medicine
41. The Efficacy of Colesevelam HCl in the Treatment of Heterozygous Familial Hypercholesterolemia in Pediatric and Adult Patients
    Michael Davidson · 2013 · Clinical Therapeutics
42. Lomitapide: A novel agent for the treatment of homozygous familial hypercholesterolemia
    Kyle Davis, Marta A. Miyares · 2014 · American Journal of Health-System Pharmacy
43. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia
    Pãmela R.S. Silva, Cinthia E. Jannes, Júlia Daher Carneiro Marsiglia, José Eduardo Krieger, Raul Dias Santos, Alexandre C. Pereira · 2016 · Atherosclerosis
44. The very high cardiovascular risk in heterozygous familial hypercholesterolemia: Analysis of 734 French patients
    Sophie Béliard, A. Millier, Valérie Carreau, Alain Carrié, Philippe Moulin, Alexandre Fredenrich, Michel Farnier, Gérald Luc, David H. Rosenbaum, Mondher Toumi et al. · 2016 · Journal of clinical lipidology
45. The Rationale, Indications, Safety, and Use of Statins in the Pediatric Population
    Michael Khoury, Brian W. McCrindle · 2020 · Canadian Journal of Cardiology
46. The Impact of Various Types of Exercise on Lipid Metabolism in Patients with Type 2 Diabetes and Concurrent Overweight/Obesity: A Narrative Review
    Sameer Badri Al-Mhanna, Wan Syaheedah Wan Ghazali, Alexios Batrakoulis, Nouf H. Alkhamees, Clemens J. Drenowatz, Mahaneem Mohamed, Mehmet Gülü, Hafeez Abiola Afolabi, Georgian Bădicu · 2024 · Annals of Applied Sport Science
47. Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.
    Pawana Sharma, Dwayne Boyers, Charles Boachie, F Stewart, Zosia Miedzybrodzka, W Simpson, Mary M Kilonzo, Paul McNamee, Graham Mowatt · 2012 · Health Technology Assessment
48. Familial Hypercholesterolemia: Cascade Screening in Children and Relatives of the Affected
    Nitika Setia, Renu Saxena, Jitendra P. S. Sawhney, Ishwar C. Verma · 2018 · The Indian Journal of Pediatrics
49. Therapeutic Apheresis for Management of Lp(a) Hyperlipoproteinemia
    Sergei N. Pokrovsky, Olga I. Afanasieva, Ежов Марат Владиславович · 2020 · Current Atherosclerosis Reports
50. Angiopoietin-like 3: An important protein in regulating lipoprotein levels
    Kendall H. Burks, Debapriya Basu, Ira J. Goldberg, Nathan O. Stitziel · 2022 · Best Practice & Research Clinical Endocrinology & Metabolism
51. The potential of mipomersen, an ApoB synthesis inhibitor, to reduce necessity for LDL-apheresis in patients with heterozygous familial hypercholesterolemia and coronary artery disease
    Anja Vogt, Klaus Georg Parhofer · 2013 · Expert Opinion on Pharmacotherapy
52. Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia
    Ingrid Brænne, Benedikt Reiz, Anja Medack, Mariana Kleinecke, Marcus Fischer, Salih Tuna, Christian Hengstenberg, Panos Deloukas, Jeanette Erdmann, Heribert Schunkert · 2014 · BMC Cardiovascular Disorders
53. Understanding Implementation Challenges to Genetic Testing for Familial Hypercholesterolemia in the United States
    Rachele Hendricks‐Sturrup, Christine Y. Lu · 2019 · Journal of Personalized Medicine
54. The doctor's dilemma: Challenges in the diagnosis and care of homozygous familial hypercholesterolemia
    Seth J. Baum, Eric J.G. Sijbrands, Pedro Mata, Gerald Francis Watts · 2014 · Journal of clinical lipidology
55. Apolipoprotein Gene Polymorphisms (APOB, APOC111, APOE) in the Development of Coronary Heart Disease in Ethnic Groups of Kazakhstan.
    Salim Berkinbayev, M Rysuly, Abdurashid A. Mussayev, Kenneth Blum, N Baitasova, Aisulu Mussagaliyeva, Г А Джунусбекова, B Makhatov, Aa Mussayev, Ainur Yeshmanova et al. · 2014 · PubMed
56. Depicting new pharmacological strategies for familial hypercholesterolaemia involving lipoprotein (a)
    Alpo F. Vuorio, Gerald Francis Watts, Petri T. Kovanen · 2017 · European Heart Journal
57. Advances with lipid-lowering drugs for pediatric patients with familial hypercholesterolemia
    Filipe Ferrari, Vítor Magnus Martins, Viviane Zorzanelli Rocha, Raul Dias Santos · 2020 · Expert Opinion on Pharmacotherapy
58. New Frontiers in the Treatment of Homozygous Familial Hypercholesterolemia
    Arturo Cesaro, Fabio Fimiani, Felice Gragnano, Elisabetta Moscarella, Alessandra Schiavo, Andrea Vergara, Leo E. Akioyamen, Laura D’Erasmo, Maurizio Rocco Averna, Marcello Arca et al. · 2021 · Heart Failure Clinics
59. Cholesterol- and lanolin-rich diets may protect against steroid-induced osteonecrosis in rabbits
    Garida Zhao, Takuaki Yamamoto, Goro Motomura, Ryosuke Yamaguchi, Satoshi Ikemura, Kenyu Iwasaki, Yukihide Iwamoto · 2013 · Acta Orthopaedica
60. Current Phase II proprotein convertase subtilisin/kexin 9 inhibitor therapies for dyslipidemia
    Paul Lee, Robert Alexander Hegele · 2013 · Expert Opinion on Investigational Drugs
61. Knowledge and Awareness of Familial Hypercholesterolaemia among Registered Medical Practitioners in Tamil Nadu: Are They Suboptimal?
    Nandhini Rangarajan · 2016 · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH
62. Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies
    Andrew C. Martin, Damon A. Bell, Tom Brett, Gerald Francis Watts · 2017 · Current Opinion in Lipidology
63. Current Treatment of Familial Hypercholesterolaemia
    Cameron T. Lambert, Pratik B. Sandesara, Ijeoma Isiadinso, María Carolina Góngora, Danny J. Eapen, Neal Kumar Bhatia, Jefferson Baer, Laurence S. Sperling · 2014 · European Cardiology Review
64. The evaluation and management of patients with LDL-C ≥ 190 mg/dL in a large health care system
    Candace L. Jackson, Zahid Ahmad, Sandeep R. Das, Amit Khera · 2020 · American Journal of Preventive Cardiology
65. Case-finding and genetic testing for familial hypercholesterolaemia in primary care
    Nadeem Qureshi, Ralph Kwame Akyea, Brittany Dutton, Steve Eric Humphries, Hasidah Abdul Hamid, Laura A. Condon, Stephen Franklin Weng, Joe Kai · 2021 · Heart
66. Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
    Stefan Walzer, Karin U. Travers, Sebastian Rieder, Erazo-Fischer, Matusiewicz · 2013 · ClinicoEconomics and Outcomes Research
67. HELP apheresis in hypercholesterolemia and cardiovascular disease: efficacy and adverse events after 8,500 procedures
    Frank van Buuren, Sven Kreickmann, Dieter Horstkotte, Tanja Kottmann, Klaus Peter Mellwig · 2012 · Clinical Research in Cardiology Supplements
68. Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial
    Patrick M. Moriarty, Klaus Georg Parhofer, Stephan P. Babirak, Emil M. deGoma, Paul Barton Duell, Bernd Hohenstein, Wolfgang Ramlow, Vinaya Simha, Elisabeth Steinhagen‐Thiessen, Paul D. Thompson et al. · 2016 · Journal of clinical lipidology
69. Familial hypercholesterolemia in Chinese patients with premature ST-segment-elevation myocardial infarction: Prevalence, lipid management and 1-year follow-up
    Ranshaka Auckle, Binjie Su, Hailing Li, Siling Xu, Mujin Xie, Yangchun Song, Mohammed Abdul Quddus, Yawei Xu, Ban Liu, Wenliang Che · 2017 · PLoS ONE
70. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
    Christos V. Rizos, Vasilios Gabriel Athyros, Eleni Bilianou, George Panagiotis Chrousos, Anastasia Garoufi, Genovefa D. Kolovou, Vasilios Kotsis, Lοukianos S. Rallidis, Emmanouel Skalidis, Ioannis Skoumas et al. · 2017 · HORMONES
71. Molecular aspects of hypercholesterolemia treatment: current perspectives and hopes
    Najmeh Ahangari, Majid Ghayour‐Mobarhan, Amirhossein Sahebkar, Alireza Pasdar · 2018 · Annals of Medicine
72. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening
    Rachel Schwiter, Emily E. Brown, Brittney A. Murray, Iris Kindt, Erin A. Van Enkevort, Toni I. Pollin, Amy Curry Sturm · 2020 · Journal of Genetic Counseling
73. Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades
    Avishay Elis, Rong Zhou, Evan A. Stein · 2013 · Cardiology in the Young
74. Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia
    Manal Al-Kindi, Alexandre M. Bélanger, Karl Sayegh, Soumia Imène Senouci, Sumayah Aljenedil, Lojan Sivakumaran, Isabelle L. Ruel, Khalid Al‐Rasadi, Khalid Al Waili, Zuhier Ahmed Awan et al. · 2017 · Canadian Journal of Cardiology
75. Familial Hypercholesterolemia and the Founder Effect Among Franco-Americans: A Brief History and Call to Action
    Reed Mszar, Sara Buscher, Heidi L. Taylor, Mary Rice-DeFosse, Dervilla McCann · 2020 · CJC Open
76. Genetic and Clinical Characteristics of Patients With Homozygous and Compound Heterozygous Familial Hypercholesterolemia From Three Different Populations: Case Series
    Tatiana Marusic, Urša Šuštar, Fouzia Sadiq, Vjosa Mulliqi Kotori, Matej Mlinarič, Jernej Kovač, Saeed Shafi, Iqbal Khan, Matija Cevc, Katarina Trebušak Podkrajšek et al. · 2020 · Frontiers in Genetics
77. Improving the detection of familial hypercholesterolaemia
    Nick S.R. Lan, Andrew C. Martin, Tom Brett, Gerald Francis Watts, Damon A. Bell · 2018 · Pathology
78. Validity and reliability of an adapted questionnaire measuring knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia
    Ahmad Baihaqi Azraii, Anis Safura Ramli, Zaliha Ismail, Suraya Abdul-Razak, Siti Fatimah Badlishah-Sham, Noor Alicezah Mohd Kasim, Norsiah Ali, Gerald Francis Watts, Hapizah Mohd Nawawi · 2021 · BMC Cardiovascular Disorders
79. Molecular analysis of the LDLR gene in coronary artery disease patients from the Indian population
    Kandasamy Nagarajan ArulJothi, R.A. Whitthall, Marta Futema, Steve Eric Humphries, Melvin George, S. Elangovan, Devaki R. Nair, Arikketh Devi · 2016 · Clinical Biochemistry
80. Investigation of the underlying genes and mechanism of familial hypercholesterolemia through bioinformatics analysis
    Dinghui Wang, Bin Liu, Tianhua Xiong, Wenlong Yu, Qiang She · 2020 · BMC Cardiovascular Disorders
81. Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand
    Michael M. Page, Winita Hardikar, George Alex, Sue Bates, Shubha Srinivasan, Michael Stormon, Kat Hall, Helen Evans, Peter S. Johnston, John Li Chen et al. · 2023 · Atherosclerosis
82. Recommendations for the Management of Patients with Familial Hypercholesterolemia
    David I. Feldman, Michael Joseph Blaha, Raul Dias Santos, Steve R. Jones, Roger Scott Blumenthal, Peter Paul Toth, Laurence S. Sperling, Seth Shay Martin · 2014 · Current Atherosclerosis Reports
83. Progress in the care of familial hypercholesterolaemia: 2016
    Damon A. Bell, Gerald Francis Watts · 2016 · The Medical Journal of Australia
84. Pediatric Statin Administration: Navigating a Frontier with Limited Data
    Jonathan B. Wagner, Susan M. Abdel‐Rahman · 2016 · The Journal of Pediatric Pharmacology and Therapeutics
85. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service
    Barak Zafrir, Ayman Jubran, Gil Lavie, David A. Halon, Moshe Y. Flugelman, Chen Shapira · 2017 · European Journal of Preventive Cardiology
86. Advances in dyslipidemia management for prevention of atherosclerosis: PCSK9 monoclonal antibody therapy and beyond
    Nathan D. Wong, Paul D. Rosenblit, Robert S. Greenfield · 2017 · Cardiovascular Diagnosis and Therapy
87. A Global Review on the Utility of Genetic Testing for Familial Hypercholesterolemia
    Rachele Hendricks‐Sturrup, Jodi Clark-LoCascio, Christine Y. Lu · 2020 · Journal of Personalized Medicine
88. Lipoprotein-apheresis: Austrian consensus on indication and performance of treatment
    Kurt Derfler, Sabine Steiner, Helmut F. Sinzinger · 2015 · Wiener klinische Wochenschrift
89. Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): Are we coming to a consensus?
    Steve Eric Humphries · 2011 · Atherosclerosis Supplements
90. Familial Hypercholesterolemia and the 2013 American College of Cardiology/American Heart Association Guidelines: Myths, Oversimplification, and Misinterpretation Versus Facts
    Joshua W. Knowles, Neil J. Stone, Christie Mitchell Ballantyne · 2015 · The American Journal of Cardiology
91. Consenso de expertos sobre la detección y el manejo clínico de la hipercolesterolemia familiar
    L. Masana, Fernando Civeira, Juan Pedro‐Botet, Isabel de Castro-Orós, Miguel Pocovı́, Núria Plana, Rocío Mateo‐Gállego, Estíbaliz Jarauta, Àngels Pedragosa · 2013 · Clínica e Investigación en Arteriosclerosis
92. First Case Report of Familial Hypercholesterolemia in an Omani Family Due to Novel Mutation in the Low-Density Lipoprotein Receptor Gene
    Ali Talib Al-Hinai, Abdulrahim Al‐Abri, Humoud Al-Dhuhli, Khalid Al-Waili, Hilal Ali Al-Sabti, Saif Al-Yaarubi, Khamis Al-Hashmi, Yajnavalka Banerjee, Ibrahim S Al-Zakwani, Khalid Al‐Rasadi · 2012 · Angiology
93. Seven-year clinical follow-up of a Chinese homozygous familial hypercholesterolemia child with premature xanthomas and coronary artery disease—A need for early diagnosis and aggressive treatment
    Long Jiang, Feng Gao, Libin Hu, Liyuan Sun, Xiao-Dong Pan, Jie Lin, Haibo Zhang, Yong Qiang, Qian Wang, Ya Yang et al. · 2014 · International Journal of Cardiology
94. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17)
    P. Elliott Miller, Seth Shay Martin, Peter Paul Toth, Raul Dias Santos, Michael Joseph Blaha, Khurram Nasir, Salim S. Virani, Wendy S. Post, Roger Scott Blumenthal, Steven Richard Jones · 2015 · Journal of clinical lipidology
95. YangXue QingNao Wan and Silibinin Capsules, the Two Chinese Medicines, Attenuate Cognitive Impairment in Aged LDLR (+/-) Golden Syrian Hamsters Involving Protection of Blood Brain Barrier
    Youyu Gu, Ping Cheong Huang, Quan Li, Yuying Liu, Chaojie Liu, Yuhui Wang, Ming Yi, Li Yan, Xiao‐Hong Wei, Lei Yang et al. · 2018 · Frontiers in Physiology
96. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention
    Maximilian Tscharre, Robert Herman, Miklós Rohla, Edita Piacková, Kris G. Vargas, Serdar Farhan, Matthias Karl Freynhofer, Thomas Werner Weiss, Kurt Huber · 2018 · Journal of clinical lipidology
97. Saudi Familial Hypercholesterolemia Patients With Rare LDLR Stop Gain Variant Showed Variable Clinical Phenotype and Resistance to Multiple Drug Regimen
    Zuhier Ahmed Awan, Omran Mohammed Rashidi, Bandar Yahya Alshehri, Kaiser Jamil, Ramu Elango, Jumana Yousuf Al-Aama, Robert Alexander Hegele, Babajan Banaganapalli, Noor Ahmad Shaik · 2021 · Frontiers in Medicine
98. A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology?
    Gerald Francis Watts, DAVID R. SULLIVAN, Frank M. VAN BOCKXMEER, Nicola Kazia Poplawski, Ian R Hamilton‐Craig, Peter Marshall Clifton, Richard Charles O’Brien, Warrick Bishop, Peter Myles George, Christopher Semsarian et al. · 2012 · Heart Lung and Circulation
99. Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol
    Laney K. Jones, Samuel S. Gidding, Terry Seaton, Anne Carol Goldberg, Christina M. Gregor, Amy Curry Sturm, Ross C. Brownson, Alanna Kulchak Rahm, Marc S. Williams · 2019 · Research in Social and Administrative Pharmacy
100. Dyslipidemia in Pediatric Patients: A Cross-Sectional Study
     Andreea Teodora Constantin, Corina Delia, Lucia Maria Tudor, Ioana Roșca, Ana Daniela Irimie, Leonard Năstase, Ioan Gherghina · 2023 · Medicina